Frontlight ResearchEarly access
CompletedNo phase
Prospective Observational Trial of IAPA
Key facts
- Who runs it
- Radboud University Medical Center
- Where
- Belgium, France, and Netherlands12 sites in 3 countriesChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 241 people enrolled
- Started
- 10 Mar 2022
- Ended
- 18 May 2026
- Type of study
- Observational, 2 groups
- Treatments tested
- Identification of biomarkers for IAPA via patient sampling
- Record updated
- 18 June 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Patients with a PCR-positive respiratory virus panel (RVP) result for influenza within 96 hours before or 48 hours after ICU admission
- Patients who require ICU admission for more than 24 hours for severe influenza
- Patients who have respiratory distress (respiratory rate >= 25x/minute and paO2/fiO2 < 300 with or without bilateral infiltrates) as the main reason for ICU admission
- Patients who do not have an EORTC host factor
- Patients who are at least 18 years of age
Who cannot take part
- Patients with age < 18 years as extensive sampling is required
- Expected survival on ICU admission ≤ 48h
- Patients that are being treated actively with antifungal agents for invasive aspergillosis
- Patients or their legal representatives who did not sign the informed consent form
This trial has no sites in United States.
It has sites in 3 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
A prospective multi-center observational study to assess the incidence of influenza-associated pulmonary aspergillosis (IAPA) in ICU patients and to identify host- and pathogen related risk factors for IAPA in EORTC negative ICU patients with severe influenza.
The 2 groups in the trial
- IAPA+
Influenza patients who develop IAPA during ICU admission
Treatment: Identification of biomarkers for IAPA via patient sampling
- IAPA-
Influenza patients admitted to the ICU not developing IAPA
Treatment: Identification of biomarkers for IAPA via patient sampling
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Influenza-associated Pulmonary Aspergillosis (IAPA) in ICU Patients With Severe Influenza: Incidence and Host- and Pathogen Related Risk Factors
- Record updated
- 18 June 2026